Last updated: July 13, 2026
AI models applied to sinus-rhythm ECGs now detect occult paroxysmal atrial fibrillation across multiple populations, and wearable AI monitoring systems report high AF detection sensitivity in randomized and cohort studies. This capability now extends beyond atrial fibrillation, as automated ECG interpretation can predict life-threatening ventricular arrhythmias before clinical onset, creating a window for intervention that manual review rarely provides.
Rhythm360 ingests CIED transmissions from all major device manufacturers, including Medtronic, Boston Scientific, Abbott, and Biotronik, into a single dashboard, so clinicians receive prioritized arrhythmia alerts without toggling between OEM portals. As Andrew Beaser, MD, Associate Professor of Medicine at the University of Chicago Medicine, noted after implementing Rhythm360, “We are able to address these issues earlier; rather than waiting for a 3-month visit, we can call patients in for evaluation.”
Remote monitoring reduces total heart failure hospitalizations by approximately 19% (IRR 0.81) per a 2026 meta-analysis of 79 randomized trials, and a virtual home health heart failure program evaluated in JMIR Cardio (2025) reported a 30-day readmission rate of 10.2%, compared to a historical benchmark of approximately 20%. A 2025 AHRQ evidence synthesis across chronic disease RPM programs reported readmission reductions ranging from 28% to 40% when remote monitoring was combined with structured nurse escalation pathways, highlighting the value of pairing continuous data with clear action plans.
Rhythm360’s integrated HF service line monitors fluid trends, weight, and physiological signals continuously, so care teams can adjust medications before a patient decompensates instead of reacting after an emergency admission. The platform connects early risk signals to predefined escalation pathways, which aligns directly with the evidence base and supports sustained reductions in heart-failure readmissions.
Alert fatigue has become a documented operational crisis in multi-OEM environments. A cross-manufacturer analysis of 2,659 rhythm episodes found that 32.9% of flagged episodes in AI-equipped devices were non-actionable, and in older ICM devices without built-in AI, 45.4% of alerts were non-actionable, which overwhelms staff and delays true emergencies.
Rhythm360 addresses this problem with an AI-powered triage layer that filters non-actionable noise and surfaces only clinically significant events, reducing critical alert response times by up to 80%. Optional 24/7/365 oversight by certified cardiac technicians (CCTs) adds a human layer of review, so high-volume programs maintain clinical accuracy without burning out staff.
As Andrew Beaser, MD, at UCM observed, “Decision support, including AI-assisted decision support, will become increasingly important as data volumes grow.”
Predictive analytics healthcare delivers measurable financial returns when paired with compliant billing workflows that capture all eligible RPM activity. The primary RPM CPT codes in 2026 include:
A fully compliant RPM program using CPT codes 99453, 99454, 99457, and 99458 generates approximately $170 per patient per month, yielding $204,000 in annual revenue at 100 enrolled patients. Revenue often goes uncaptured on 99457 and 99458 because of time-tracking gaps, and Rhythm360’s automated reporting closes that documentation gap. Gaurav A. Upadhyay, MD, at UCM confirmed, “We have improved billing and accountability for our patients after the integration.” Practices using Rhythm360 frequently report revenue increases approaching 300% when they fully document eligible RPM work.
Cardiovascular data exhibits inherent heterogeneity across modalities, devices, parameters, and standards, creating substantial inconsistencies that limit the robustness and generalizability of analytical models. This academic challenge translates directly into operational chaos for practices that manage devices from more than one OEM, where incompatible data formats, separate portals, and fragmented patient views make unified analysis difficult.
Rhythm360 resolves this fragmentation through API, HL7, XML, and PDF parsing with computer vision and AI-powered data normalization. A redundant data feed system acts as a fail-safe when an OEM server is unavailable, which achieves greater than 99.9% transmissibility. The result is a single, auditable source of truth across every CIED and RPM device in a practice’s population.
Many of the most clinically significant moments in cardiac monitoring occur outside business hours, such as a patient whose CIED transmits new-onset atrial fibrillation on a Saturday morning. Without a unified platform, that alert sits unreviewed in an OEM portal until Monday, and the opportunity for early intervention disappears.
With Rhythm360, the alert is triaged, prioritized, and routed to the on-call clinician’s mobile device within minutes. By Saturday afternoon, the patient is evaluated and started on anticoagulation therapy, and a potential stroke is prevented. This shift from detection to intervention in hours rather than days reflects the operational reality Rhythm360 enables through its HIPAA-compliant mobile app and intelligent alerting infrastructure.
University of Chicago Medicine processed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter, which shows that this level of responsiveness scales to high-volume academic environments without degrading review quality.
Cardiology practices that manage multiple device manufacturers face both technical and operational barriers when they adopt predictive analytics healthcare.
On the technical side, legacy systems lack interoperability, data formats are inconsistent across manufacturers, and lab units vary, which degrades model accuracy. Traditional analytical methods often lack scalability to coordinate data from diverse devices and environments and frequently require bespoke models tailored to specific signal types.
On the operational side, security and privacy risks require end-to-end encryption, role-based access controls, and HIPAA compliance, and staff resistance to workflow changes slows deployment. Alert routing that lands outside existing clinical inboxes creates parallel workflows that providers eventually abandon.
Rhythm360 addresses these barriers through bi-directional EHR integration with Epic, Cerner, Athenahealth, eClinicalWorks, and other systems via HL7, combined with a SaaS deployment model that typically completes onboarding in days to weeks.
A structured implementation approach reduces disruption and accelerates time-to-value for predictive analytics programs. The following checklist translates five interdependent imperatives for scaling RPM beyond pilots—data convergence, AI on unified data, workflow-embedded recommendations, continuous outcome tracking, and built-in governance into concrete steps for your team.
Published evidence from 2025 and 2026 consistently shows 30% to 50% reductions in heart failure readmissions when remote monitoring is combined with AI-driven alert triage and structured escalation pathways. The AHRQ synthesis mentioned earlier supports this range, and a JMIR Cardio 2025 virtual home health program achieved a 30-day readmission rate of 10.2% against a historical benchmark of approximately 20%. The strongest outcomes occur when risk segmentation is applied at discharge and first-contact outreach happens within 48 hours of an alert, and Rhythm360 supports both through automated triage and integrated communication tools.
The primary CPT codes for RPM billing in 2026 are 99453 for device setup as a one-time service, 99454 for device supply with 16 or more days of data transmission per month, 99457 for the first 20 minutes of interactive clinical staff time per month, and 99458 for each additional 20-minute increment. CPT 99091 covers physician collection and interpretation of physiologic data for a minimum of 30 minutes per 30-day period and is particularly relevant for cardiologists who review high volumes of rhythm and hemodynamic data. For CIED-specific monitoring, CPT codes 93298 and 93299 apply to remote interrogation of implantable cardioverter-defibrillators and pacemakers. Revenue is most commonly lost on 99457 and 99458 because of inadequate time-tracking documentation, and Rhythm360’s automated reporting and audit-ready documentation directly address this gap so practices that capture all applicable codes see significant improvements in billing revenue.
Each major device manufacturer, including Medtronic, Boston Scientific, Abbott, and Biotronik, operates its own proprietary portal with a distinct data format, transmission schedule, and alert logic. A practice that manages patients with devices from all four manufacturers must maintain separate logins, reconcile conflicting data structures, and manually aggregate findings before making clinical decisions.
A vendor-neutral platform like Rhythm360 ingests data from all OEM sources simultaneously using API connections, HL7 feeds, XML parsing, and computer vision-based PDF extraction. AI-powered normalization maps disparate data fields into a standardized schema, and redundant data feeds ensure continuity when an OEM server is unavailable. The result is a single dashboard where a clinician or device technician sees every patient’s complete device history, alert status, and transmission record without switching systems, which achieves greater than 99.9% transmissibility and removes the administrative burden of multi-portal management.
University of Chicago Medicine implemented Rhythm360 to overhaul its cardiovascular remote monitoring program for CIED and heart failure patients. In calendar year 2025, UCM processed more than 73,000 reports annually through the platform, averaging more than 18,000 reports per quarter, with stable dismissal rates that indicate consistent review quality at scale. Clinicians reported the ability to review more transmissions daily and identify more abnormalities than was possible with the prior fragmented workflow, and the platform enabled earlier interventions by prompting evaluations based on transmission findings rather than waiting for scheduled three-month visits. UCM also reported improved billing accountability following integration, which reflects the revenue capture benefits of automated CPT documentation at high volume.
Fragmented OEM portals, missed critical alerts, and lost CPT revenue are operational problems with a documented solution. Rhythm360 unifies every CIED and RPM data stream into one AI-powered, vendor-neutral dashboard, so practices can detect arrhythmias earlier, prevent heart failure readmissions, eliminate alert fatigue, and capture the billing revenue their programs have already earned.
University of Chicago Medicine processed more than 73,000 reports annually at scale, and practices using Rhythm360 have reduced critical alert response times by up to 80% while increasing revenue by as much as 300%. Implementation typically takes days to weeks, not months.
